SCHEMBL7985693

SCHEMBL7985693

CC(=O)NCCc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.59
ALDH1A1 P00352 3/20 0.59
HPGD P15428 1/20 0.58
KMT2A Q03164 2/20 0.50
HTT P42858 1/20 0.46
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
BRD4 O60885 1/20 0.43
EGLN1 Q9GZT9 2/20 0.41
GFER P55789 1/20 0.40
RAB9A P51151 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PNP P00491 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987702 0.87 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7991666 0.86 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2APARN
Hydrochloric Acid SCHEMBL7987857 0.86 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7985704 0.84 CNOT7 (0.50) SMN1; SMN2ALDH1A1HPGDKMT2AHTT
SCHEMBL7989405 0.83 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7988836 0.83 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2APARN
Hydrochloric Acid SCHEMBL7975095 0.82 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7987608 0.81 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7985634 0.81 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7985298 0.81 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1HPGDKMT2APARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed